曜亞

+0.70 (+1.32%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

53.6018成交張數14.64本益比1.35股價淨值比7.84%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	30	16	39.6%	2.17	39.56	9.6%	5.0%	0.7	0.6
2026Q1	32	16	42.7%	1.97	39.54	9.6%	4.7%	-0.3	-0.5
2025Q4	31	17	39.5%	2.16	41.79	9.5%	5.0%	2.5	2.4
2025Q3	30	16	39.2%	2.22	39.99	11.5%	6.0%	0.4	0.3
2025Q2	29	15	41.2%	2.14	40.57	13.0%	6.5%	0.8	0.7
2025Q1	30	14	44.5%	1.99	39.03	14.3%	6.6%	-0.5	-0.7
2024Q4	30	15	41.4%	2.19	42.32	13.4%	6.8%	1.9	1.7
2024Q3	29	14	42.5%	2.07	39.75	13.2%	6.9%	-0.2	-0.5
2024Q2	29	14	46.4%	1.85	42.60	13.5%	6.9%	0.2	0.0
2024Q1	31	14	50.2%	1.69	41.09	14.8%	7.0%	0.3	0.1
2023Q4	31	15	44.6%	1.94	46.55	14.4%	7.3%	1.7	1.4
2023Q3	29	15	42.3%	2.07	46.52	13.6%	7.2%	0.7	0.5
2023Q2	29	15	43.0%	1.86	50.77	12.6%	6.6%	0.8	0.6
2023Q1	27	14	42.3%	1.92	46.47	11.5%	5.9%	0.4	0.4
2022Q4	27	14	42.0%	1.98	46.26	10.3%	5.5%	1.8	1.3
2022Q3	25	13	40.4%	2.20	44.22	10.8%	6.0%	0.9	0.7
2022Q2	25	13	42.3%	2.05	42.17	10.8%	5.7%	0.2	0.0
2022Q1	24	12	40.6%	2.17	41.12	10.3%	5.5%	-0.1	-0.4
2021Q4	23	13	36.0%	2.50	42.80	9.6%	5.5%	1.0	1.0
2021Q3	22	13	33.6%	2.62	41.77	9.0%	5.3%	0.8	0.7
2021Q2	22	12	36.8%	2.37	40.96	9.4%	5.3%	0.3	0.1
2021Q1	22	12	37.4%	2.36	40.52	10.0%	5.4%	0.6	0.5
2020Q4	21	13	31.7%	2.77	43.03	9.0%	5.3%	0.9	0.9
2020Q3	21	13	31.7%	2.76	42.24	9.5%	5.8%	1.0	1.0
2020Q2	22	12	35.4%	2.42	41.23	9.3%	5.3%	0.4	0.4
2020Q1	22	12	37.7%	2.27	39.39	9.6%	5.4%	0.2	0.1
2019Q4	22	13	34.0%	2.52	42.72	8.8%	5.3%	1.5	1.2
2019Q3	20	12	29.7%	3.03	41.66	7.7%	5.0%	0.2	0.2
2019Q2	22	12	35.4%	2.48	41.33	8.4%	4.9%	0.4	0.4
2019Q1	22	13	33.0%	2.70	43.66	7.9%	4.9%	0.5	0.5
2018Q4	20	13	29.0%	2.76	42.37	8.4%	4.9%	1.5	1.4
2018Q3	19	13	24.8%	3.21	42.52	9.4%	5.8%	0.2	0.2
2018Q2	21	12	33.0%	2.45	41.16	9.5%	5.2%	-0.0	-0.1
2018Q1	21	13	28.5%	2.66	44.14	8.7%	5.2%	-0.2	-0.2
2017Q4	23	12	39.0%	2.05	41.33	9.0%	4.9%	1.3	1.1
2017Q3	21	12	36.0%	2.21	40.35	9.0%	5.2%	-0.2	-0.2
2017Q2	23	12	41.6%	1.93	39.50	9.3%	5.0%	0.2	0.1
2017Q1	22	13	36.3%	2.21	42.19	8.8%	5.1%	0.2	0.2
2016Q4	23	13	37.5%	3.28	42.36	–	–	0.7	0.7
2016Q3	21	13	34.2%	3.83	42.14	–	–	0.8	0.7